Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Washington University School of Medicine Bristol-Myers Squibb ImClone Systems |
---|---|
Information provided by: | Washington University School of Medicine |
ClinicalTrials.gov Identifier: | NCT00292955 |
The anti-tumor activity of cetuximab prior to chemoradiotherapy and the safety and tolerability of cetuximab with concurrent chemoradiation will be determined in women with locally advanced or metastatic cervical carcinoma.
Condition | Intervention | Phase |
---|---|---|
Cancer of the Cervix |
Drug: Cetuximab |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | An Exploratory Pharmacogenomic Study of Neoadjuvant Cetuximab Followed by Cisplatin, Radiotherapy, and Cetuximab in Women With Newly Diagnosed Locally Advanced or Metastatic Cervical Carcinoma |
Estimated Enrollment: | 30 |
Study Start Date: | February 2006 |
Estimated Primary Completion Date: | February 2011 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Kathryn Britton | 314-747-4126 | brittonk@ccadmin.wustl.edu |
Contact: Stephanie Myles | 314-747-4223 | myless@ccadmin.wustl.edu |
United States, Missouri | |
Washington University School of Medicine | Recruiting |
St. Louis, Missouri, United States, 63110 |
Principal Investigator: | Paula M Fracasso, M.D., Ph.D. | Washington University School of Medicine |
Responsible Party: | University of Virginia ( Paula M. Fracasso, M.D., Ph.D. ) |
Study ID Numbers: | 05-0702, CA225243 |
Study First Received: | February 14, 2006 |
Last Updated: | October 27, 2008 |
ClinicalTrials.gov Identifier: | NCT00292955 |
Health Authority: | United States: Food and Drug Administration |
Cervical Cancer, Cetuximab, Phase II Clinical Trials Stage IB2-IVB Carcinoma of the Cervix |
Genital Diseases, Female Uterine Cervical Neoplasms Uterine Cervical Diseases Cisplatin Cetuximab Genital Neoplasms, Female |
Uterine Diseases Uterine Neoplasms Urogenital Neoplasms Neoplasms, Glandular and Epithelial Carcinoma |
Neoplasms Neoplasms by Site Neoplasms by Histologic Type |
Antineoplastic Agents Therapeutic Uses Pharmacologic Actions |